K6 (Clonazepam (dispersible) 0.25 mg)
Pill imprint K6 has been identified as Clonazepam (dispersible) 0.25 mg.
Clonazepam is used in the treatment of anxiety; benzodiazepine withdrawal; restless legs syndrome; panic disorder; bipolar disorder (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Clonazepam 0.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- 0.25 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Benzodiazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
sodium lauryl sulfate
Note: Inactive ingredients may vary.
More about clonazepam
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1071 Reviews – Add your own review/rating
- Drug class: benzodiazepine anticonvulsants
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.